Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of KRX stocks as of Dec 20th which has an aggregated short interest worth USD3.5bn.</li>
<li>We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in SCD (000250 KS) , SKC (011790 KS) , Yuhan (000100 KS).</li>
</ul>


We analyzed the changes in short interest of KRX stocks as of Dec 20th which has an aggregated short interest worth USD3.5bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in SCD (000250 KS) , SKC (011790 KS) , Yuhan (000100 KS).


KRX Short Interest Weekly (Dec 20th):SCD, SKC, Yuhan

Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/classys" target="_blank" data-smartkarma-citation="entities:29688:1" rel="noopener">Classys (214150 KS)</a> reported solid performance in 2Q23, with revenue and operating profit growing 40% and 52%, YoY, respectively, mainly driven by consumables sales in both domestic and overseas markets.  </li>
<li>Despite increase in advertising and R&amp;D expenses, operating profit margin expanded 370 basis points to 50.4%. Net profit increased 34% YoY to KRW18.6 billion.</li>
<li>With 1H23 revenue of KRW84.9 billion, Classys is on track to meet 2023 revenue guidance of KRW170 billion, representing year-over-year increase of 20%.</li>
</ul>



Classys (214150 KS) reported solid performance in 2Q23, with revenue and operating profit growing 40% and 52%, YoY, respectively, mainly driven by consumables sales in both domestic and overseas markets.  
Despite increase in advertising and R&amp;D expenses, operating profit margin expanded 370 basis points to 50.4%. Net profit increased 34% YoY to KRW18.6 billion.
With 1H23 revenue of KRW84.9 billion, Classys is on track to meet 2023 revenue guidance of KRW170 billion, representing year-over-year increase of 20%.


Classys (214150 KS): Beautiful Growth Story Continues; No Sign of Slowing Down

<ul>
<li>
<a href="https://www.smartkarma.com/entities/classys" target="_blank" data-smartkarma-citation="entities:29688:1" rel="noopener">Classys (214150 KS)</a> reported solid performance in 1Q23, with double-digit revenue growth, driven by expansion of domestic consumables sales for Shrink Universe and growth in overseas device and consumables sales.</li>
<li>Operating profit increased 19% YoY to KRW 19.9 billion, leading to 380 basis point margin expansion to 51%. Net profit increased 46% YoY to KRW 18.8 billion.</li>
<li>Classys continues to strengthen its competitiveness through product line and geography expansion. The company has reiterated 2023 revenue guidance of KRW170 billion, representing year-over-year increase of 20%.</li>
</ul>



Classys (214150 KS) reported solid performance in 1Q23, with double-digit revenue growth, driven by expansion of domestic consumables sales for Shrink Universe and growth in overseas device and consumables sales.
Operating profit increased 19% YoY to KRW 19.9 billion, leading to 380 basis point margin expansion to 51%. Net profit increased 46% YoY to KRW 18.8 billion.
Classys continues to strengthen its competitiveness through product line and geography expansion. The company has reiterated 2023 revenue guidance of KRW170 billion, representing year-over-year increase of 20%.


Classys (214150 KS): Strong 1Q23 Result Lifted by Overseas Performance and Consumables Sales

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Cross Asset Strategy

<p>The Korea Exchange announced its KOSDAQ150 and KRX300 indices rebalances today. There were 17 new additions and 17 deletions for KOSDAQ150. </p><p>Most of the stocks that were expected to be included in KOSDAQ 150 were officially included in the rebalance. However there were a few surprises. For example <a href="https://www.smartkarma.com/entities/nanos-co-ltd" target="_blank" data-smartkarma-citation="entities:16796:1" rel="noopener">Nanos Co Ltd (151910 KS),</a>which was one of the stocks that was expected to be included in KOSDAQ150, did not get included in this indext this time. On the other hand, the following stocks including <a href="https://www.smartkarma.com/entities/sang-a-frontec-co-ltd" target="_blank" data-smartkarma-citation="entities:20692:1" rel="noopener">Sang A Frontec (089980 KS)</a>, Novarex (194700 KS(, CIS (222080 KS), MedPacto (215980 KS), <a href="https://www.smartkarma.com/entities/koreacenter-com-co-ltd" target="_blank" data-smartkarma-citation="entities:28329:1" rel="noopener">Koreacenter.com Co Ltd (290510 KS)</a>, and Soulbrain (357780 KS) which were not on the top of the lists of getting selected into the KOSDAQ150 index by the locals, were formally selected be part of the new KOSDAQ150 inclusions.  </p><p>The Korea Exchange also made changes to the KRX300 index. Although the KRX300 index is not currently as important as KOSPI200 and KOSDAQ150 indices, it is increasingly gaining in importance among the local institutional investors. The KRX300 had 33 new additions and 35 deletions. </p>

The Korea Exchange announced its KOSDAQ150 and KRX300 indices rebalances today. There were 17 new additions and 17 deletions for KOSDAQ150. Most of the stocks that were expected to be included in KOSDAQ 150 were officially included in the rebalance. However there were a few surprises. For example Nanos Co Ltd (151910 KS),which was one of the stocks that was expected to be included in KOSDAQ150, did not get included in this indext this time. On the other hand, the following stocks including Sang A Frontec (089980 KS), Novarex (194700 KS(, CIS (222080 KS), MedPacto (215980 KS), Koreacenter.com Co Ltd (290510 KS), and Soulbrain (357780 KS) which were not on the top of the lists of getting selected into the KOSDAQ150 index by the locals, were formally selected be part of the new KOSDAQ150 inclusions.  The Korea Exchange also made changes to the KRX300 index. Although the KRX300 index is not currently as important as KOSPI200 and KOSDAQ150 indices, it is increasingly gaining in importance among the local institutional investors. The KRX300 had 33 new additions and 35 deletions. 

KOSDAQ150 and KRX300 Indices Rebalances (Overlapping Additions & Deletions)

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Event-Driven

<p>The KRX has announced the list of inclusions and exclusions to the KOSDAQ150 Index today. The rebalance is effective after the close of trading on 10 December.</p><p>There are 17 inclusions and 17 exclusions in the December 2020 review with an estimated one-way turnover of 7.71%.</p><p>The inclusions and exclusions are:</p><table class="table table-striped">
<colgroup><col span="4"></colgroup>
<tbody>
<tr>
<td colspan="2" style="text-align: center; width: 96pt;"><h3>Additions</h3></td>
<td colspan="2" style="text-align: center; width: 96pt;"><h3>Deletions</h3></td>
</tr>
<tr>
<td style="text-align: center;"><strong>Code</strong></td>
<td style="text-align: center;"><strong>Name</strong></td>
<td style="text-align: center;"><strong>Code</strong></td>
<td style="text-align: center;"><strong>Name</strong></td>
</tr>
<tr>
<td>034950.KQ</td>
<td>Korea Ratings Corp</td>
<td>014620.KQ</td>
<td>Sung Kwang Bend Co Ltd</td>
</tr>
<tr>
<td>078600.KQ</td>
<td>Daejoo Electronic Materials Co Ltd</td>
<td>015750.KQ</td>
<td>Sungwoo Hitech Co Ltd</td>
</tr>
<tr>
<td>089980.KQ</td>
<td>Sang-A Frontec Co Ltd</td>
<td>023160.KQ</td>
<td>TK Corp</td>
</tr>
<tr>
<td>092190.KQ</td>
<td>Seoul Viosys Co Ltd</td>
<td>039840.KQ</td>
<td>Dio Corp</td>
</tr>
<tr>
<td>100130.KQ</td>
<td>Dongkuk Structures &amp; Construction Co Ltd</td>
<td>041190.KQ</td>
<td>Woori Technology Investment Co Ltd</td>
</tr>
<tr>
<td>101490.KQ</td>
<td>S&amp;S Tech Corp</td>
<td>041830.KQ</td>
<td>InBody Co Ltd</td>
</tr>
<tr>
<td>131370.KQ</td>
<td>Rsupport Co Ltd</td>
<td>043150.KQ</td>
<td>Value Added Technology Co Ltd</td>
</tr>
<tr>
<td>137400.KQ</td>
<td>People &amp; Technology Inc</td>
<td>047310.KQ</td>
<td>Power Logics</td>
</tr>
<tr>
<td>194700.KQ</td>
<td>Novarex Co Ltd</td>
<td>049950.KQ</td>
<td>MeereCompany Inc</td>
</tr>
<tr>
<td>204270.KQ</td>
<td>JNTC Co Ltd</td>
<td>051500.KQ</td>
<td>CJ Freshway Corp</td>
</tr>
<tr>
<td>222080.KQ</td>
<td>Creative &amp; Innovative System Corp</td>
<td>063570.KQ</td>
<td>Nice Total Cash Management Co Ltd</td>
</tr>
<tr>
<td>235980.KQ</td>
<td>MedPacto Inc</td>
<td>080160.KQ</td>
<td>Modetour Network Inc</td>
</tr>
<tr>
<td>290510.KQ</td>
<td>KoreaCenter Co Ltd</td>
<td>084110.KQ</td>
<td>Huons Global Co Ltd</td>
</tr>
<tr>
<td>290650.KQ</td>
<td>L&amp;C Bio Co Ltd</td>
<td>089600.KQ</td>
<td>Nasmedia Co Ltd</td>
</tr>
<tr>
<td>293490.KQ</td>
<td>Kakao Games Corp</td>
<td>115960.KQ</td>
<td>Yonwoo Co Ltd</td>
</tr>
<tr>
<td>294140.KQ</td>
<td>Lemon Co Ltd</td>
<td>228760.KQ</td>
<td>Genomictree Inc</td>
</tr>
<tr>
<td>357780.KQ</td>
<td>SoulBrain Co Ltd</td>
<td>282880.KQ</td>
<td>CowinTech Co Ltd</td>
</tr>
</tbody>
</table><p>There are 11 trading days to implementation. There are 2 additions that have more than 3 days of ADV to trade while there are 9 deletions that have more than 3 days of ADV to trade. Things could get interesting over the next couple of weeks.</p>

The KRX has announced the list of inclusions and exclusions to the KOSDAQ150 Index today. The rebalance is effective after the close of trading on 10 December.There are 17 inclusions and 17 exclusions in the December 2020 review with an estimated one-way turnover of 7.71%.The inclusions and exclusions are:



Additions
Deletions


Code
Name
Code
Name


034950.KQ
Korea Ratings Corp
014620.KQ
Sung Kwang Bend Co Ltd


078600.KQ
Daejoo Electronic Materials Co Ltd
015750.KQ
Sungwoo Hitech Co Ltd


089980.KQ
Sang-A Frontec Co Ltd
023160.KQ
TK Corp


092190.KQ
Seoul Viosys Co Ltd
039840.KQ
Dio Corp


100130.KQ
Dongkuk Structures &amp; Construction Co Ltd
041190.KQ
Woori Technology Investment Co Ltd


101490.KQ
S&amp;S Tech Corp
041830.KQ
InBody Co Ltd


131370.KQ
Rsupport Co Ltd
043150.KQ
Value Added Technology Co Ltd


137400.KQ
People &amp; Technology Inc
047310.KQ
Power Logics


194700.KQ
Novarex Co Ltd
049950.KQ
MeereCompany Inc


204270.KQ
JNTC Co Ltd
051500.KQ
CJ Freshway Corp


222080.KQ
Creative &amp; Innovative System Corp
063570.KQ
Nice Total Cash Management Co Ltd


235980.KQ
MedPacto Inc
080160.KQ
Modetour Network Inc


290510.KQ
KoreaCenter Co Ltd
084110.KQ
Huons Global Co Ltd


290650.KQ
L&amp;C Bio Co Ltd
089600.KQ
Nasmedia Co Ltd


293490.KQ
Kakao Games Corp
115960.KQ
Yonwoo Co Ltd


294140.KQ
Lemon Co Ltd
228760.KQ
Genomictree Inc


357780.KQ
SoulBrain Co Ltd
282880.KQ
CowinTech Co Ltd


There are 11 trading days to implementation. There are 2 additions that have more than 3 days of ADV to trade while there are 9 deletions that have more than 3 days of ADV to trade. Things could get interesting over the next couple of weeks.

KOSDAQ150 Index Rebalance: Lots of Changes, Big Turnover, High Impact

South Korea

InBody Co., Ltd. manufactures and markets a body composition analyzer and other related medical instruments.  The Company supplies its products to the hospitals, clinics, fitness clubs, and households.  Biospace also exports its products to overseas markets, such as America, Europe, and Asia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Inbody Co Ltd (041830 KS)

KRX Short Interest Weekly (Dec 20th):SCD, SKC, Yuhan

We analyzed KRX short interest report for the past week and highlighted short interest changes in SCD (000250 KS) , SKC (011790 KS) , Yuhan (000100...

Ke Yan, CFA, FRM

Classys (214150 KS): Beautiful Growth Story Continues; No Sign of Slowing Down

Classys reported strong 2Q23 performance, with revenue and operating profit growing 40% and 52% YoY, driven by consumables sales. The company...

Tina Banerjee

Classys (214150 KS): Strong 1Q23 Result Lifted by Overseas Performance and Consumables Sales

Since publishing this insight, Classys shares gained 26%. Investors can book partial profit and hold core position, as more upside is seen, due to...

Tina Banerjee

KOSDAQ150 and KRX300 Indices Rebalances (Overlapping Additions & Deletions)

We highlight the KOSDAQ150 and KRX300 indices rebalances. There are some interesting new names, especially among those that are over lapping in...

Douglas Kim

KOSDAQ150 Index Rebalance: Lots of Changes, Big Turnover, High Impact

There are 17 changes to the KOSDAQ150 index and the turnover is estimated at 7.71%. There are a lot of stocks that have over 3 days of ADV to trade...

Brian Freitas

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

KRX Short Interest Weekly (Dec 20th):SCD, SKC, Yuhan

We analyzed KRX short interest report for the past week and highlighted short interest changes in SCD (000250 KS) , SKC (011790 KS) , Yuhan (000100...

Ke Yan, CFA, FRM

Classys (214150 KS): Beautiful Growth Story Continues; No Sign of Slowing Down

​Classys reported strong 2Q23 performance, with revenue and operating profit growing 40% and 52% YoY, driven by consumables sales. The company...

Tina Banerjee

Classys (214150 KS): Strong 1Q23 Result Lifted by Overseas Performance and Consumables Sales

Since publishing this insight, Classys shares gained 26%. Investors can book partial profit and hold core position, as more upside is seen, due to...

Tina Banerjee

KOSDAQ150 and KRX300 Indices Rebalances (Overlapping Additions & Deletions)

We highlight the KOSDAQ150 and KRX300 indices rebalances. There are some interesting new names, especially among those that are over lapping in...

Douglas Kim

KOSDAQ150 Index Rebalance: Lots of Changes, Big Turnover, High Impact

There are 17 changes to the KOSDAQ150 index and the turnover is estimated at 7.71%. There are a lot of stocks that have over 3 days of ADV to trade...

Brian Freitas

Classys reported strong 2Q23 performance, with revenue and operating profit growing 40% and 52% YoY, driven by consumables sales. The company...